Nuveen Asset Management, LLC Immunity Bio, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 506,425 shares of IBRX stock, worth $3.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

506,425

Previous 522,477 3.07%

Holding current value

$3.18 Million

Previous $2.62 Million 3.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.23 - $6.17 $51,847 - $99,040	-16,052 Reduced 3.07%	506,425 $2.72 Million
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $56,497 - $235,481	45,198 Added 9.47%	522,477 $2.62 Million
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $61,344 - $147,417	47,554 Added 11.07%	477,279 $806,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $289,384 - $1.21 Million	189,140 Added 78.62%	429,725 $1.19 Million
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $11,222 - $39,736	-8,313 Reduced 3.34%	240,585 $437,000

Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $91,719 - $142,745	-21,085 Reduced 7.81%	248,898 $3.83 Million
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $14,070 - $24,787	-3,855 Reduced 1.41%	269,983 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $13,083 - $29,975	-4,882 Reduced 1.75%	273,838 $1.02 Million
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $856,267 - $1.28 Million	-169,558 Reduced 37.82%	278,720 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $1.03 Million - $1.85 Million	181,842 Added 68.25%	448,278 $2.73 Million
Q3 2021 Nov 12, 2021	SELL	$9.17 - $14.24 $2.86 Million - $4.44 Million	-311,464 Reduced 53.9%	266,436 $2.6 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $7.75 Million - $12.9 Million	577,900 New	577,900 $1.73 Million

Others Institutions Holding IBRX

# of Institutions

191

Shares Held

66.7M

Call Options Held

2.27M

Put Options Held

3.23M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $2.51B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Immunity Bio, Inc. Transaction History